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Abstract 
Background: Indoor residual spraying (IRS) and long‑lasting insecticidal nets (LLINs) remain the cornerstones of 
malaria vector control. However, the development of insecticide resistance and its implications for operational failure 
of preventative strategies are of concern. The aim of this study was to characterize insecticide resistance among 
Anopheles arabiensis populations in Ethiopia and describe temporal and spatial patterns of resistance between 2012 
and 2016.
Methods: Between 2012 and 2016, resistance status of An. arabiensis was assessed annually during the long rainy 
seasons in study sites from seven of the nine regions in Ethiopia. Insecticide resistance levels were measured with 
WHO susceptibility tests and CDC bottle bioassays using insecticides from four chemical classes (organochlorines, 
pyrethroids, organophosphates and carbamates), with minor variations in insecticides tested and assays conducted 
between years. In selected sites, CDC synergist assays were performed by pre‑exposing mosquitoes to piperonyl 
butoxide (PBO). In 2015 and 2016, mosquitoes from DDT and deltamethrin bioassays were randomly selected, identi‑
fied to species‑level and screened for knockdown resistance (kdr) by PCR.
Results: Intense resistance to DDT and pyrethroids was pervasive across Ethiopia, consistent with historic use of DDT 
for IRS and concomitant increases in insecticide‑treated net coverage over the last 15 years. Longitudinal resistance 
trends to malathion, bendiocarb, propoxur and pirimiphos‑methyl corresponded to shifts in the national insecticide 
policy. By 2016, resistance to the latter two insecticides had emerged, with the potential to jeopardize future long‑
term effectiveness of vector control activities in these areas. Between 2015 and 2016, the West African (L1014F) kdr 
allele was detected in 74.1% (n = 686/926) of specimens, with frequencies ranging from 31 to 100% and 33 to 100% 
in survivors from DDT and deltamethrin bioassays, respectively. Restoration of mosquito susceptibility, following pre‑
exposure to PBO, along with a lack of association between kdr allele frequency and An. arabiensis mortality rate, both 
indicate metabolic and target‑site mutation mechanisms are contributing to insecticide resistance.
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Background
Despite the scaling-up of key diagnostic, treatment and 
preventative measures, malaria remains a considerable 
public health problem in Ethiopia, with over 50.6 mil-
lion (60% of the total population) at significant risk [1]. 
Transmission of Plasmodium falciparum and Plasmo-
dium vivax is highly heterogeneous and unstable across 
the country, concentrated in lowland and highland fringe 
areas [2]. Unlike other sub-Saharan countries, where 
malaria morbidity and mortality mainly impacts young 
children, in Ethiopia, low levels of immunity predispose 
many individuals to clinically severe malaria and epi-
demics among all age groups. As part of the National 
Malaria Strategic Plan (2014–2020), vector control by 
the National Malaria Control Programme (NMCP), with 
support from the President’s Malaria Initiative (PMI) and 
the Global Fund, is based on indoor residual spraying 
(IRS) and universal coverage campaigns of long-lasting 
insecticidal nets (LLINs) [1–4].
IRS was first implemented in Ethiopia in 1959 and con-
tinues to play a prominent role in malaria control. LLIN 
coverage has been scaled up since 2005, resulting in over 
64 million nets distributed by 2014 [2]. However, the 
long-term effectiveness of both strategies is currently 
under threat from widespread emergence of insecticide 
resistance in the principal malaria vector, Anopheles ara-
biensis [3]. To date, in Ethiopia, An. arabiensis has devel-
oped resistance against insecticides belonging to all 
four chemical classes approved for IRS, including DDT 
(organochlorine), malathion (organophosphate), bendio-
carb and propoxur (carbamates) and alpha-cypermethrin, 
cyfluthrin, deltamethrin, etofenprox, lambda-cyhalothrin 
and permethrin (pyrethroids) [5–14]. The West African 
kdr (L1014F) mutation has been reported in An. arabi-
ensis populations at high frequencies [9, 14, 15] and pre-
exposure of An. arabiensis to piperonyl butoxide (PBO) 
significantly increased vector susceptibility to deltame-
thrin and permethrin [12], suggesting both metabolic 
and target-site mutation mechanisms are responsible for 
insecticide resistance. Historically, DDT, and to a lesser 
extent, malathion were used for IRS in Ethiopia [12]. In 
2010, vector control by the NMCP, with support from 
PMI, discontinued DDT spraying in favour of deltame-
thrin, which was used initially in combination with ben-
diocarb from 2011, before being superseded exclusively 
by bendiocarb and propoxur in 2013. In 2015, in response 
to incipient resistance, PMI-supported IRS activities were 
based on bendiocarb in 28 districts (and focal pirimiphos-
methyl application in 8 districts) and in 2016, pirimiphos-
methyl replaced bendiocarb in all PMI-supported districts 
[2] (Fig. 1 and Additional file 1: Table S1).
Considering only a limited number of alternate insec-
ticides are available for public health use, the aim of this 
study was to characterize contemporary nationwide 
insecticide resistance in An. arabiensis populations and 
describe longitudinal trends in resistance between 2012 
and 2016, to strengthen the NMCP’s insecticide resist-
ance monitoring and management strategy and safeguard 
continued efficacy of IRS in Ethiopia [16].
Methods
Study sites
Data are from study sites in seven of the nine regions 
[Afar, Amhara, Benishangul Gumuz, Gambela, Oromia, 
Southern Nations, Nationalities, and Peoples’ Region 
(SNNPR), and Tigray] in Ethiopia between 2012 and 
2016.
Susceptibility tests
For all susceptibility tests, mosquito larvae were col-
lected by dipping from a range of breeding sites in each 
study area and reared to adults under standard insec-
tary conditions (temperature 25 ± 2  °C, relative humid-
ity 80 ± 10%). Bioassays were conducted annually during 
the long rainy season (June–September). WHO tube tests 
and CDC bottle bioassays were used to determine sus-
ceptibility levels of Anopheles gambiae s.l. populations 
(henceforth An. arabiensis) to different insecticides, with 
minor variations in insecticides tested and assays con-
ducted between years (Additional file 1: Table S2). From 
2014 onwards, CDC resistance intensity assays were 
undertaken and synergist assays were also performed by 
pre-exposing mosquitoes to PBO in selected sites. For all 
assays, care was taken during storage and field transpor-
tation of insecticide-impregnated papers and technical 
grade insecticide stock solutions to reduce heat exposure 
and minimize potential loss of efficacy.
WHO susceptibility tests
World Health Organization (WHO) susceptibility tests 
for the following eleven insecticides with diagnostic 
doses (alpha-cypermethrin (0.05%), bendiocarb (0.1%), 
Conclusions: Data generated by this study will strengthen the National Malaria Control Programme’s insecticide 
resistance management strategy to safeguard continued efficacy of IRS and other malaria control methods in 
Ethiopia.
Keywords: Insecticide resistance, Anopheles arabiensis, Resistance mechanisms, Intensity assays, Malaria, kdr, Ethiopia
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DDT (4%), deltamethrin (0.05%), etofenprox (0.5%), feni-
trothion (1%), lambda-cyhalothrin (0.05%), malathion 
(5%), permethrin (0.75%), pirimiphos-methyl (0.25%) and 
propoxur (0.1%)) were conducted according to WHO 
guidelines [17]. The diagnostic dose of insecticides used 
on papers is generally twice the  LC99 values systemati-
cally determined from baseline studies in multiple loca-
tions [18]. In 2012, four replicates of 20–25 non-blood 
fed, 2-3 days old adult female mosquitoes were exposed 
to different insecticide-impregnated papers in WHO 
tubes for 1  h (except in the case of fenitrothion where 
mosquitoes were exposed for 2  h) and in parallel, one 
replicate of control mosquitoes (20–25 mosquitoes per 
tube) was exposed to oil-impregnated papers; from 2013 
onwards, two control replicates using 25 mosquitoes 
were performed. For all assays, mosquito mortality was 
recorded after a 24-h holding period. Cotton wool soaked 
in 10% sugar solution was provided to mosquitoes on top 
of the holding tube and optimum temperature and rela-
tive humidity was maintained using a damp towel placed 
on top of boxes where holding tubes were kept.
CDC bottle bioassays
CDC bottle bioassays for seven insecticides (alpha-
cypermethrin, bendiocarb, DDT, deltamethrin, lambda-
cyhalothrin, permethrin and propoxur) were conducted 
according to published guidelines [19]. Stock solu-
tions were prepared by diluting technical grade insecti-
cide in 50 mL of acetone. Each Wheaton 250 mL bottle 
along with its cap was coated with 1  mL of stock solu-
tion (12.5  µg/bottle for alpha-cypermethrin, bendio-
carb, deltamethrin, lambda-cyhalothrin and propoxur, 
100  µg/bottle for DDT and 21.5  µg/bottle for perme-
thrin) by rolling and inverting the bottles. In each test, a 
control bottle was coated with 1 mL of acetone. Follow-
ing coating, bottles were covered with mats and left to 
dry. Approximately, 10–25 non-blood fed, 2–3  days old 
adult female mosquitoes were introduced into each bot-
tle using a mouth aspirator and mortality was recorded 
at 15  min intervals up to 30  min for all insecticides 
except DDT; for this assay mosquitoes were exposed for 
45  min. From 2014 onwards, CDC resistance  intensity 
assays were performed by testing 1, 2, 5 and 10 times the 
concentration required to kill all mosquitoes  (LC100), as 
determined in a series of baseline experiments [19], and 
in selected sites, synergist assays were also conducted by 
pre-exposing mosquitoes to PBO for 1 h (100 µg/bottle).
Molecular identification of Anopheles gambiae species 
complex
Mosquitoes used in bioassay tests were identified mor-
phologically using standard keys [20]. In 2015 and 2016, 
sub-samples of both surviving and dead mosquitoes from 
WHO tests were randomly selected by insecticide (DDT 
and deltamethrin), site and region for molecular species 
identification and kdr allele detection at the Molecular 
Biology Laboratory, Tropical and Infectious Diseases 
Research Centre (TIDRC) of Jimma University. Genomic 
Fig. 1 Maps of Oromia Region, Ethiopia displaying insecticides used for IRS activities in PMI‑supported districts from 2010 to 2016. Note there have 
been changes in district boundaries over this time period. Additionally, deltamethrin LLINs have been distributed en masse across all regions since 
2010
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DNA was extracted following the procedure described by 
Collins et al. [21]. DNA was re-suspended in 25 ml sterile 
TE-buffer (10 mM Tris–HCl pH 8, 1 mM EDTA). Molec-
ular identification of An. gambiae s.l. was carried out by 
species-specific PCR using primers for An. gambiae s.s., 
An. arabiensis and Anopheles quadriannulatus species B 
(Anopheles amharicus) according to Scott et al. [22], with 
modifications [9, 23]. Briefly, genomic DNA was mixed 
with primers AR (5′-AAGTGTCCTTCTCCATCCRA-3′; 
specific for An. arabiensis), AG (5′-CTGGTTTGGTCG-
GCACGTTT-3; specific for An. gambiae s.s.), QD-b 
(5′-AGTGTCCAATGTCTGTGAAG-3′; specific for An. 
quadriannulatus species B) and UN (5′-GTGTGCC-
CCTTCCTCGATGT-3′; common for all species) in a 
25 μL reaction. Amplification reactions contained 1 μL of 
DNA, 1.5 mM  MgCl2, 10 mM Tris–HCl (pH 8.4), 50 mM 
KCl, 0.1% Triton X-100, 200 μM of dNTPs (Amersham, 
Buckinghamshire, United Kingdom), 25  pmol of prim-
ers AR, AG, QD-b and UN and 0.25 U of SilverStar DNA 
polymerase (Eurogentec, Seraing, Belgium) [24]. PCR 
reaction conditions are described in Scott et  al. [22]. 
Amplified PCR products were visualized on 2% agarose 
gels, stained with ethidium bromide. An. arabiensis strain 
from the Sekoru colony, maintained at the Vector Biology 
and Control Research Unit, TIDRC, Jimma University, 
was used as a positive control.
Detection of resistance mutations
West African kdr (L1014S) and East African kdr 
(L1014F) alleles were detected using adapted protocols 
[24] for allele-specific PCR (AS-PCR), developed by 
Martinez-Torres et al. [25] and Ranson et al. [26]. Prim-
ers Agd1 (5′-ATAGATTCCCCGACCATG-3′), Agd2 
(5′-AGACAAGGATGATGAACC-3′), Agd3 (5′-AATTT-
GCATTACTTACGACA-3′) and Agd4 (5′-CTGTAGT-
GATAGGAAATTTA-3′) were used to detect the L1014F 
allele (AS-PCR Agd3), whereas primers Agd1, Agd2, 
Agd4 and Agd5 (5′-TTTGCATTACTTACGACTG-3′) 
were used to detect the L1014S allele (AS-PCR Agd5). 
Amplifications were performed in 50 μL reactions con-
taining 2  μL DNA, 1× Qiagen PCR buffer, 0.5  mM 
 MgCl2, 100  nM of each primer, 200  μM dNTPs, and 
1U Taq DNA polymerase (Taq PCR core kit, Qiagen, 
Hilden, Germany). The cycling conditions were: initial 
94 °C denaturation for 5 min, 10 cycles of 1 min denatur-
ation at 94 °C, 30 s annealing at 54 °C and 30 s extension 
at 72 °C, followed by 30 cycles of 1 min denaturation at 
94 °C, 30 s annealing at 47 °C and 30 s extension at 72 °C, 
and a final extension at 72 °C for 10 min. Amplification 
products were visualized on 2% agarose gels, stained 
with ethidium bromide. An. arabiensis from the Sekoru 
colony (a kdr negative mosquito strain) was used as a 
negative control.
Data analysis
Data were interpreted according to the WHO guide-
lines [17]; mortality of 98% or higher in susceptibil-
ity tests indicates susceptibility, mortality of 90–97% 
is suggestive of resistance and mortality of less than 
90% indicates resistance. Mortality was corrected using 
Abbott’s formula, when mortality in control assays was 
between 5 and 20% [17, 27]. A bioassay was repeated if 
control mortality exceeded 20%. Per site, mean percent 
mosquito mortality was determined across all repli-
cates for a given insecticide. Pearson’s Chi squared tests 
were used to evaluate the association of kdr frequency 
with WHO assay results and to test for deviations from 
Hardy–Weinberg equilibrium. Cohen’s Kappa (κ) was 
calculated to quantify the magnitude of agreement 
between WHO susceptibility tests and CDC bottle bioas-
says [28]; values were interpreted as poor (κ ≤ 0), slight 
(0 < κ ≤ 0.2), fair (0.2 < κ ≤0.4), moderate (0.4 < κ ≤0.6), 
substantial (0.6 < κ ≤0.8) and almost perfect agreement 
(0.8 < κ ≤1.0) [29]. All statistical analyses were performed 
in Stata/IC 14.2 (Stata Corp., College Station, USA) with 
the level of significance set at α = 0.05.
Results
WHO susceptibility tests
Results from WHO susceptibility tests conducted in eight 
sentinel sites (Alamata, Amibara, Asendabo, Bahir Dar, 
Chewaka, Halaba, Lare and Ziway-Dugda) between 2012 
and 2016 are summarized in Table  1 and Fig.  2. WHO 
tests conducted in additional areas from 2013 onwards 
are detailed in Additional file 1: Tables S3–S6 by year. 
In 2012, high levels of pyrethroid resistance were evi-
dent across Ethiopia, with An. arabiensis mortality lev-
els of 50% or less for alpha-cypermethrin, deltamethrin, 
etofenprox, lambda-cyhalothrin and permethrin. Simi-
larly, all mosquito populations were highly resistant to 
DDT (mortality ranging from 0 to 13%) and demonstrated 
variable levels of susceptibility to the organophosphate 
malathion (26–90% mortality) (Table 1). In contrast, An. 
arabiensis was fully susceptible to organophosphates 
fenitrothion and pirimiphos-methyl and the carbamate 
propoxur, with the exception of Chewaka, where average 
mortality for the latter was 96%. Low levels of developing 
bendiocarb (carbamate) resistance were detected in three 
study sites, Asendabo, Bahir Dar and Chewaka (mortality 
of 93, 87 and 90%, respectively).
In 2015–2016, most An. arabiensis populations pre-
sented consistent susceptibility profiles, with minor 
variations in some resistance levels; notably in four sites 
(Asendabo, Chewaka, Halaba and Ziway-Dugda) suscep-
tibility to malathion increased over time (from 66 to 83%, 
58 to 96%, 48 to 96% and 90 to 98% average mosquito 
mortality, respectively), while mosquito mortality to 
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pirimiphos-methyl began to decline slightly in Asendabo 
and Ziway-Dugda (from 100 to 98% and 100 to 99% mor-
tality, respectively) and possible resistance to propoxur 
emerged in Ziway-Dugda (94% mortality) and Bahir 
Dar (97% mortality). Resistance to pirimiphos-methyl 
and propoxur was also detected in additional study sites 
from Oromia region; An. arabiensis mortality was 85% in 
Babile in 2016 to pirimiphos-methyl, and 75% and 95% to 
propoxur in Abaya in 2013 and in Nono in 2016, respec-
tively (Additional file 1: Tables S3, S6). Interestingly, vec-
tors from an area of sesame cultivation sampled in 2016 
(Metema; Amhara Region) demonstrated almost com-
plete susceptibility to deltamethrin (average mortality of 
99%; Additional file 1: Table S6).
Similar longitudinal trends were observed in Alamata, 
Lare and Amibara, where resistance monitoring began in 
2014 (Table 1). In these areas, at baseline, vector popu-
lations were also resistant to pyrethroids and DDT, fully 
susceptible to fenitrothion, pirimiphos-methyl and pro-
poxur and potentially resistant to bendiocarb in Alamata 
and Lare (mortality of 96 and 92%, respectively). In these 
latter two sites, resistance to malathion was also detected 
(mortality of 89 and 95%, respectively). By 2016, puta-
tive resistance to pirimiphos-methyl had developed in 
Alamata (mortality of 92%) and to malathion in Amibara 
(mortality of 96%). On a yearly basis, levels of resistance 
fluctuated within sites, in some cases modestly (e.g. in 
Asendabo, mortality to bendiocarb oscillated from 93% 
in 2012, to 86% in 2014, 95% in 2015 and 80% in 2016) 
and in others more dramatically, beyond what might be 
expected of stochastic variation (e.g. in Bahir Dar, mor-
tality to malathion ranged from 26% in 2012, to 89% in 
2014 and 43% in 2015).
CDC bottle bioassays
From 2013 onwards, CDC bottle bioassays, resistance 
intensity and synergist assays were conducted in addi-
tional study sites, which differed between years (Addi-
tional file  1: Tables S7–S10). Data from Ziway-Dugda, 
where these tests were performed routinely throughout 
the monitoring period are presented in Fig. 3 and Addi-
tional file  1: Table S11, in comparison with concurrent 
WHO bioassays. Results from both WHO tests (diagnos-
tic dose) and CDC bottle bioassays (2X) were concordant 
for bendiocarb and propoxur; vector populations were 
fully susceptible to both insecticides until 2016. How-
ever, levels of pyrethroid resistance were not compara-
ble between techniques, e.g. An. arabiensis mortality in 
2014 to deltamethrin was 11% in WHO tests, compared 
to 70% in CDC bottle bioassays at the same discrimina-
tory dose (κ ≤ 0, for all comparisons between pyrethroid 
assays in 2014, 2015 and 2016).
While consistently high levels of pyrethroid resistance 
were observed using WHO tests, examination of CDC 
bioassays from additional study areas identified some 
completely susceptible An. arabiensis populations, e.g. 
mortality was 100% to deltamethrin in Abedogoro at the 
equivalent WHO diagnostic dose (2X) in 2015. Focal 
Fig. 2 Maps of Ethiopia displaying trends in An. arabiensis susceptibility levels to bendiocarb, deltamethrin, malathion, permethrin, pirimiphos‑
methyl and propoxur, as measured using WHO susceptibility tests, between 2012 (left) and 2015/16 (right). Vector populations were sampled from 
eight sentinel sites (Alamata, Amibara, Asendabo, Bahir Dar, Chewaka, Halaba, Lare and Ziway Dugda) in six regions. Legend colours indicate the 
insecticide under evaluation, with darker shading denoting average mosquito mortality
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patterns of pyrethroid resistance were also apparent in 
2013, where vector populations, susceptible to one or 
more pyrethroids, were identified in eleven areas across 
three regions (Additional file 1: Table S7). In these sites 
resistance to a particular pyrethroid was not necessar-
ily associated with increased tolerance to another, e.g. 
in Gobu-Seyo (Oromia Region) mosquito mortality was 
76, 49, 98 and 8% to alpha-cypermethrin, deltamethrin, 
lambda-cyhalothrin and permethrin at the CDC   diag-
nostic doses, respectively. In other areas with high lev-
els of pyrethroid resistance, CDC resistance intensity 
assays detected some mosquitoes capable of surviving 
ten times the diagnostic dose of deltamethrin or perme-
thrin (e.g. average mortality of 75 and 65% in Asendabo 
in 2015, respectively; Additional file 1: Table S9). High 
intensities of DDT resistance were also observed in 
these areas, e.g. 95% of mosquitoes survived ten times 
the diagnostic dose in Wondogenet in 2014 (Additional 
file 1: Table S8).
In all sites where mosquitoes were pre-exposed to PBO, 
a synergist that interferes with oxidase activity, resist-
ance to both deltamethrin and permethrin was reduced, 
increasing mortality to 87–100% when mosquitoes were 
exposed to the 1X dose (Additional file 1: Tables S8–S11).
Molecular detection of species and resistance mutations
Following WHO susceptibility tests in 2015, three hun-
dred and sixty-four surviving and dead An. gambiae s.l. 
specimens were randomly selected from eight study sites 
in six regions [Asendabo, Chewaka, Ziway-Dugda (Oro-
mia region), Bahir Dar (Amhara region), Amibara (Afar 
region), Alamata (Tigray region), Halaba (SNNPR) and 
Abobo (Gambela region)] and were assayed to determine 
species. Of these, 94.8% (345/364) of samples ampli-
fied and were identified as An. arabiensis. Non-amplifi-
ers were evenly distributed across all study sites, except 
Amibara and Ziway-Dugda where all specimens were 
successfully classified. In 2016, six hundred and sixty-two 
An. gambiae s.l. were collected from ten study sites in six 
regions: Asendabo, Babile, Nono and Ziway-Dugda (Oro-
mia region), Metema (Amhara region), Amibara (Afar 
region), Abobo (Gambela region), Alamata and Humera 
(Tigray region) and Arba Minch (SNNPR), and 86.7% 
(574/662) of specimens were confirmed as An. arabien-
sis. Higher proportions of non-amplifiers were collected 
from Metema (17.6% of total mosquitoes sampled), Nono 
(30%), Arba Minch and Abobo (both 17.5%), than other 
neighboring areas (range of remaining sites: 5–12.5%).
In 2015, the presence of kdr was also assessed in 
matched mosquito samples (Table  2). The West African 
(L1014F) kdr allele was identified in 75.5% (n = 275/364) 
of specimens (215 alive and 60 dead), with allele frequen-
cies ranging from 50 to 100% and 13 to 88% in surviving 
and dead An. arabiensis from DDT bioassays, respectively, 
and from 36 to 100% and 13 to 100% in surviving and 
dead An. arabiensis from deltamethrin bioassays, respec-
tively. The majority of vectors surviving bioassays were 
homozygous for kdr (54.0%; 116/215) compared to those 
Fig. 3 Comparison of WHO and CDC bottle bioassays (at both respective diagnostic doses), conducted using bendiocarb, deltamethrin, perme‑
thrin and propoxur in Ziway‑Dugda from 2014 to 2016
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that died (23.3%; 14/60); 29.3% (63/215) and 36.7% (22/60) 
were heterozygous for kdr, respectively. The kdr-West 
allele was present in 100% of surviving vectors from one 
study site (Alamata; Tigray region) and 94% in another 
(Halaba; the SNNPR). Deviations from Hardy–Weinberg 
equilibrium were only observed in An. arabiensis sur-
vivors of deltamethrin bioassays in Asendabo and Lare 
(χ2 = 7.13; p = 0.0076 and χ2 = 7.75; p = 0.0054 respec-
tively) (Table  2). There was no significant association 
between kdr allele frequency and An. arabiensis mortal-
ity following exposure to DDT or deltamethrin (p = 0.227 
and p =  0.208, respectively). The East African (L1014S) 
kdr allele was not detected in any samples assayed.
In 2016, all mosquito specimens confirmed as An. ara-
biensis (n = 562; with the exception of 8 and 4 samples 
from Metema and Alamata, respectively) were assayed 
for kdr (Table  3). L1014F kdr was detected in 73.5% 
(n = 413/562) of An. arabiensis (322 alive and 91 dead), 
with allele frequencies ranging from 31 to 89% and 10 to 
100% in surviving and dead mosquitoes from DDT bio-
assays, respectively, and from 33 to 100% and 6 to 94% 
in surviving and dead mosquitoes from deltamethrin 
bioassays, respectively. There was no significant dif-
ferences in kdr allele frequency between years among 
DDT or deltamethrin bioassay survivors (p = 0.229 and 
p  =  0.158, respectively). As previously, the majority of 
An. arabiensis surviving bioassays were homozygous for 
kdr (42.2%; 136/322) compared to those that died (28.6%; 
26/91); 33.2% (107/322) and 28.6% (26/91) were het-
erozygous for kdr, respectively. The kdr-West allele was 
fixed in surviving vectors from two study sites (Babile 
and Nono; Oromia region); in Alamata, kdr frequencies 
had declined from 100% in 2015 to 62% and 57% among 
survivors of DDT and deltamethrin bioassays, respec-
tively. Consistent with results from 2015, deviations from 
Hardy–Weinberg equilibrium were identified among An. 
arabiensis in Asendabo (χ2  =  9.71; p  =  0.0018 for del-
tamethrin survivors) (Table  3) and in additional vector 
populations in Abobo (χ2 = 13.60; p = 0.00023, χ2 = 3.83; 
p =  0.05 for survivors of DDT and deltamethrin bioas-
says, respectively), Arba Minch (χ2 = 4.87; p = 0.027 for 
DDT survivors), Alamata (χ2 =  4.83; p =  0.028 for del-
tamethrin survivors) and Amibara (χ2 = 5.62; p = 0.018 
and χ2 = 6.53; p = 0.011 for DDT and deltamethrin sur-
vivors, respectively). There was no significant association 
between kdr allele frequency and An. arabiensis mortality 
following exposure to DDT or deltamethrin (p =  0.231 
and p = 0.267, respectively).
Discussion
The development of pervasive insecticide resistance 
across sub-Saharan Africa threatens to jeopardize the 
long-term effectiveness of both IRS and LLINs for 
malaria control [30, 31]. This study presents data from 
the largest nationwide, longitudinal monitoring of insec-
ticide resistance among An. arabiensis populations to 
four classes of insecticides in Ethiopia. Intense resist-
ance to pyrethroids (alpha-cypermethrin, deltamethrin, 
etofenprox, lambda-cyhalothrin and permethrin) and 
DDT were commonplace, and in many sites, vectors were 
able to survive exposure to five to ten times the diagnos-
tic dose. These high levels of resistance are likely a direct 
consequence of historic DDT use for IRS, as well as its 
considerable application between 2000 and 2005, where 
255,000–298,000 kg/year were used [32], alongside mass 
distributions of LLINs [2].
Patterns of resistance to bendiocarb, malathion, pro-
poxur and pirimiphos-methyl also corresponded to 
shifts in the national insecticide policy [2]. Since 2012, 
An. arabiensis susceptibility to malathion increased in 
some areas, potentially attributable to the discontinua-
tion of this insecticide for IRS; malathion was last used 
extensively for malaria control from 2003 to 2005 by 
the NMCP in areas with reported DDT resistance [5, 
9]. Between 2011 and 2015, bendiocarb (with deltame-
thrin in 2011–2012) was the insecticide of choice for 
PMI-supported IRS activities in Oromia Region, where 
low levels of mosquito resistance were initially detected 
in 2012. However, because bendiocarb was largely aban-
doned due to its short residual efficacy, relative to other 
organophosphates and carbamates [33], only moderate 
levels of resistance developed in a few areas. Concur-
rent propoxur spraying in 2012 was accompanied by the 
emergence of potential resistance in some An. arabiensis 
populations by 2014 and likewise, decreased An. arabien-
sis susceptibility to pirimiphos-methyl was observed in 
2016, concomitant with the switch to this insecticide in 
selected districts in 2015; however it should be noted that 
these sites fell outside the districts where pirimiphos-
methyl was used for IRS. In general, the reactive, and in 
some cases, heterogeneous use of different insecticides 
has resulted in highly focal, volatile resistance profiles 
across sentinel sites [34], complicating the prospective 
deployment of interventions for vector control. Study 
observations are consistent with earlier cross-sectional 
evaluations from Ethiopia [35], which also describe wide-
spread resistance to DDT and pyrethroids, as well as 
more restricted decreases in An. arabiensis susceptibility 
to malathion, bendiocarb and propoxur [5–15]. Further-
more, results from Sudan, Kenya and Eritrea corroborate 
large-scale resistance trends in An. arabiensis docu-
mented across this region [35–38].
Study results raised concerns pertaining to the com-
parability of WHO and CDC insecticide resistance tests. 
While in some areas, outcome measurements from both 
assays are reported to be equivalent in terms of resistance 
Page 10 of 14Messenger et al. Malar J  (2017) 16:469 
Ta
b
le
 3
 G
en
o
ty
p
ic
 a
n
d
 k
dr
 a
lle
le
 fr
eq
u
en
ci
es
 in
 A
no
ph
el
es
 a
ra
bi
en
si
s 
fr
o
m
 te
n
 n
at
io
n
al
 s
en
ti
n
el
 s
it
es
 in
 E
th
io
p
ia
, 2
01
6
Re
gi
on
Si
te
In
se
ct
ic
id
e
Su
rv
iv
al
 s
ta
tu
s 
af
te
r e
xp
os
ur
e
# 
m
os
q
ui
to
es
 
te
st
ed
H
om
oz
yg
ot
e 
m
ut
at
io
n
 (R
R)
H
et
er
oz
yg
ot
e 
m
ut
at
io
n
 (R
S)
H
om
oz
yg
ot
e 
w
ild
 ty
p
e 
(S
S)
kd
r a
lle
le
 
fr
eq
ue
n
cy
χ2
 te
st
P 
va
lu
e
%
 m
or
ta
lit
y 
in
 W
H
O
 te
st
s
Re
si
st
an
ce
 
st
at
us
R
S
O
ro
m
ia
Ba
bi
le
D
D
T
A
liv
e
13
7
2
0
0.
89
0.
11
1.
33
0.
24
9
11
R
D
ea
d
9
9
0
0
1
0
–
–
D
el
ta
m
e‑
th
rin
A
liv
e
15
14
0
0
1
0
–
–
22
R
D
ea
d
9
8
1
0
0.
94
0.
16
7
1.
43
1
0.
23
2
N
on
o
D
D
T
A
liv
e
12
2
3
3
0.
44
0.
56
1.
63
5
0.
20
1
29
R
D
ea
d
9
0
3
3
0.
25
0.
75
1.
44
4
0.
22
9
D
el
ta
m
e‑
th
rin
A
liv
e
8
7
0
0
1
0
–
–
52
R
D
ea
d
6
2
2
2
0.
5
0.
5
0.
66
7
0.
41
4
A
se
nd
ab
o
D
D
T
A
liv
e
28
9
11
6
0.
56
0.
44
0.
63
5
0.
42
6
10
R
D
ea
d
0
0
0
0
0
0
–
–
D
el
ta
m
e‑
th
rin
A
liv
e
25
3
12
6
0.
43
0.
57
9.
70
6
0.
00
18
4
8
R
D
ea
d
7
1
1
3
0.
3
0.
7
1.
55
1
0.
21
3
Zi
w
ay
‑
D
ug
da
D
D
T
A
liv
e
30
9
10
11
0.
47
0.
53
3.
27
2
0.
07
05
27
R
D
ea
d
10
0
2
8
0.
1
0.
9
0.
12
3
0.
72
5
D
el
ta
m
e‑
th
rin
A
liv
e
9
2
4
3
0.
44
0.
56
0.
09
2
0.
76
2
76
R
D
ea
d
8
0
1
7
0.
06
0.
94
0.
04
0.
84
1
A
m
ha
ra
M
et
em
a
D
D
T
A
liv
e
11
1
3
4
0.
31
0.
69
0.
91
4
0.
33
9
74
R
D
ea
d
8
0
1
4
0.
2
0.
8
1.
51
6
0.
21
8
D
el
ta
m
e‑
th
rin
A
liv
e
1
1
0
0
1
0
–
–
99
S
D
ea
d
0
0
0
0
0
0
–
–
SN
N
PR
A
rb
a 
M
in
ch
D
D
T
A
liv
e
28
12
7
7
0.
6
0.
4
4.
86
9
0.
02
73
51
R
D
ea
d
10
1
3
4
0.
31
0.
69
0.
50
5
0.
47
7
D
el
ta
m
e‑
th
rin
A
liv
e
22
12
8
2
0.
73
0.
27
0.
15
7
0.
69
2
41
R
D
ea
d
6
2
1
3
0.
41
0.
59
2.
61
9
0.
10
6
Ti
gr
ay
A
la
m
at
a
D
D
T
A
liv
e
30
10
12
4
0.
62
0.
38
0.
55
2
0.
45
8
34
R
D
ea
d
9
0
4
3
0.
29
0.
71
1.
30
1
0.
25
4
D
el
ta
m
e‑
th
rin
A
liv
e
20
6
5
4
0.
57
0.
43
4.
83
4
0.
02
79
50
R
D
ea
d
10
0
1
3
0.
13
0.
87
3.
63
1
0.
05
67
H
um
er
a
D
D
T
A
liv
e
27
14
6
4
0.
71
0.
29
3.
68
5
0.
05
49
33
R
D
ea
d
10
0
2
5
0.
14
0.
86
1.
04
1
0.
30
8
D
el
ta
m
e‑
th
rin
A
liv
e
24
7
6
5
0.
56
0.
44
2.
93
5
0.
08
67
39
R
D
ea
d
9
2
2
4
0.
38
0.
62
1.
64
6
0.
2
Page 11 of 14Messenger et al. Malar J  (2017) 16:469 
Ta
b
le
 3
 c
o
n
ti
n
u
ed
Re
gi
on
Si
te
In
se
ct
ic
id
e
Su
rv
iv
al
 s
ta
tu
s 
af
te
r e
xp
os
ur
e
# 
m
os
q
ui
to
es
 
te
st
ed
H
om
oz
yg
ot
e 
m
ut
at
io
n
 (R
R)
H
et
er
oz
yg
ot
e 
m
ut
at
io
n
 (R
S)
H
om
oz
yg
ot
e 
w
ild
 ty
p
e 
(S
S)
kd
r a
lle
le
 
fr
eq
ue
n
cy
χ2
 te
st
P 
va
lu
e
%
 m
or
ta
lit
y 
in
 W
H
O
 te
st
s
Re
si
st
an
ce
 
st
at
us
R
S
A
fa
r
A
m
ib
ar
a
D
D
T
A
liv
e
30
6
6
13
0.
36
0.
64
5.
61
7
0.
01
78
67
R
D
ea
d
10
0
1
4
0.
1
0.
9
2.
53
1
0.
11
2
D
el
ta
m
e‑
th
rin
A
liv
e
24
3
3
8
0.
33
0.
68
6.
52
9
0.
01
06
53
R
D
ea
d
9
0
0
5
0
1
–
–
G
am
be
la
A
bo
bo
D
D
T
A
liv
e
19
0
2
1
0.
33
0.
67
13
.5
93
0.
00
02
27
37
R
D
ea
d
9
1
0
2
0.
33
0.
67
5.
01
0.
02
52
D
el
ta
m
e‑
th
rin
A
liv
e
30
11
7
3
0.
73
0.
27
3.
82
7
0.
05
33
R
D
ea
d
8
0
1
5
0.
08
0.
92
0.
54
1
0.
46
2
Page 12 of 14Messenger et al. Malar J  (2017) 16:469 
monitoring [39, 40], our data align with others reporting 
considerable discrepancies [28, 41, 42], which were prob-
lematic to interpret, particularly when susceptibility pro-
files annually fluctuated above or below the thresholds of 
resistance set by the WHO [18, 28]. Previous studies have 
suggested that the extent of inter-assay agreement may 
reflect levels of susceptibility heterogeneity, whereby tests 
conducted on vector populations with highly variable 
resistance profiles are more prone to inconsistent results 
[28]. Indeed, direct comparisons between our WHO and 
CDC bottle bioassays performed using bendiocarb and 
propoxur (where An. arabiensis were completely sus-
ceptible), and against pyrethroids (where resistance was 
more capricious) supports this supposition. Others have 
proposed that CDC bioassays may over-estimate pyre-
throid resistance, as insecticide repellency can reduce 
the already relatively short contact time (30 min) of mos-
quitoes in coated bottles [40]. In this regard, our results 
demonstrated the opposite; higher and more uniform 
levels of pyrethroid resistance were obtained for WHO 
tests, when results were pooled across study sites.
There are a number of other technical and biological 
factors which could contribute to discordance between 
assays. WHO papers are distributed from a centralized 
source, which may render them prone to inter-batch 
variation and depending upon procurement schedules, 
can result in filter papers of different ages being used for 
the same monitoring activities in a given year. Ideally, 
to ensure consistency between study sites, all batches of 
papers would have been tested initially using a suscep-
tible laboratory strain. CDC bottle bioassays are coated 
in-house which also introduces issues of standardization 
based on the proficiency of individual laboratory techni-
cians, conditions of insecticide storage and numbers of 
consecutive times bottles are re-used [43–45]. Anoph-
eles larvae were sampled from a range of the most pro-
ductive breeding sites with different effective population 
sizes, genetic compositions, temperatures, nutritional 
access and chemical exposures depending upon local 
ecology. One important factor that was not investigated 
in this study was the influence that intensive agriculture 
pesticide use has had on resistance levels in Ethiopia 
(reviewed by [46]). Once collected, bioassays were con-
ducted on emergent adult mosquitoes who were pre-
sumed to be An. arabiensis, based on PCR validation of 
a sub-set in 2015 and 2016. It should be noted that 10.4% 
of all PCR reactions did not amplify either because of 
technical errors or the specimens did not belong to the 
species under investigation (An. gambiae s.s., An. arabi-
ensis or An. quadriannulatus species B/An. amharicus). 
Finally, WHO tests assess mortality after a 24-h hold-
ing period, while CDC bioassays measure knock-down 
and acute toxicity, which depending upon the degree of 
vector tolerance, may not necessarily be interchangeable 
[28].
Regarding the underlying mechanisms of resistance, 
the restoration of pyrethroid susceptibility following pre-
exposure to PBO and the non-association of L1014F kdr 
allele frequency with levels of An. arabiensis mortality 
in WHO bioassays, suggests that both over-expression 
of detoxification enzymes and target-site mutations are 
driving insecticide resistance. Moderate to high kdr fre-
quencies were detected in a number of sites and were 
fixed or approaching fixation in a minority. However, by 
comparison with earlier reports from the same areas, 
kdr allele frequencies were lower overall [9, 14, 47] and 
between our study years we also observed a slight, albeit 
not statistically significant, decline. In 2015, the lack of 
deviations from Hardy–Weinberg equilibrium in most 
areas indicated that selection for kdr heterozygotes was 
not ongoing, allowing this allele to be lost to genetic drift 
in some populations, but by 2016, study sites from five 
regions demonstrated evidence for kdr selection, poten-
tially resulting from a mass distribution of LLINs by the 
NMCP beginning in August 2015. Given the lack of asso-
ciation between mosquito bioassay mortality and pres-
ence/absence of kdr mutation, there are likely to be other 
mechanisms at play in the development of resistance. 
Future local surveillance programmes may wish to con-
sider screening for additional, recently identified genetic 
markers of metabolic resistance in An. arabiensis, e.g. 
CYP6P4 [48].
Conclusions
To date, the presence of insensitive acetylcholinesterase 
mutations (ace-1R or G119S), known to mediate resist-
ance to both organophosphates and carbamates in An. 
gambiae s.s. and An. arabiensis [49, 50], has not been 
reported in Ethiopia among vectors resistant to mala-
thion or propoxur [9]. The bioassay results in this study 
were not indicative of any cross-resistance both between 
organophosphates and carbamates and among chemicals 
belonging to the same insecticide class. This observation 
suggests the existence of additional metabolic resistance 
mechanisms that can confer insecticide-specific resist-
ance and also has implications for the development of 
an insecticide resistance management strategy. If inter- 
and intra-class rotation of different insecticides could be 
exploited to reduce selection pressures, this may have 
the potential to safeguard continued efficacy of IRS and 
other vector control strategies in Ethiopia and proactively 
mitigate the development of future insecticide resistance. 
Furthermore, additional epidemiological studies are war-
ranted, in parallel with future resistance monitoring activ-
ities, to determine the operational impact of insecticide 
resistance on malaria vector control in Ethiopia.
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